GFM
HUMA icon

GF Fund Management’s Humacyte HUMA Stock Holding History

GF Fund Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,203
Closed -$2.55K – 614
2026
Q1 		$2.55K Buy
4,203
+638
+18% +$663 ﹤0.01% 620
2025
Q4 		$3.42K Buy
3,565
+158
+5% +$224 ﹤0.01% 634
2025
Q3 		$5.93K Buy
3,407
+112
+3% +$219 ﹤0.01% 600
2025
Q2 		$6.89K Hold
3,295
– – ﹤0.01% 605
2025
Q1 		$5.62K Buy
3,295
+610
+23% +$2.29K ﹤0.01% 616
2024
Q4 		$13.6K Buy
+2,685
New +$13.3K ﹤0.01% 509

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GF Fund Management's HUMA Position: Q2 2026 in Review

GF Fund Management sold out of Humacyte (HUMA) in Q2 2026, closing a stake of 4,203 shares — an estimated $2.55K sold.

GF Fund Management first reported a position in HUMA in Q4 2024 and held it in 6 quarters. The position peaked at $13.6K in Q4 2024. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • GF Fund Management reported no remaining Humacyte position as of Q2 2026 after selling out during the quarter.
  • GF Fund Management sold 4,203 Humacyte shares in Q2 2026, an estimated $2.55K.
  • GF Fund Management first reported a position in Humacyte in Q4 2024 and held it in 6 quarters.
  • GF Fund Management's Humacyte position peaked at $13.6K in Q4 2024.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.